Rural South & Southeast Asia Household Health Survey

Status Completed

Clinical Trial Summary

A cross-sectional household survey with two-stage cluster-randomized sampling. This cross-sectional household survey design to recruit a random sample of households that is representative for each of the study sites. From the selected households, all consenting, household members will be included in the study. This study is funded by the UK Wellcome Trust. The grant reference number is 215604/Z/19/Z

Clinical Trial Description

371 households will be randomly selected from each site in Bangladesh, Cambodia, Myanmar, and Thailand. Assuming each household has an average of 4.5 members and all members will be sampled, 1500 participants will be recruited per site. This sample size allows for the overall prevalence estimation of key survey indicators with 95% confidence and 5% degree of precision. The survey components include questionnaire interview, physical examination, blood sample collection, and point of care (PoC) tests. The questionnaire interview will collect information on household characteristics, members' disability, presence or history of disease, risk factors, self-perceived quality of life, and health seeking behaviour. For women, questions about reproductive health and antenatal care, and for young children, vaccination coverage and achievement of child development goals, will also be assessed. For physical examinations, tympanic temperature, weight and height will be measured in all household members, mid-upper arm circumference in young children, and blood pressure in adults. Blood sample will be collected from all participants aged 6 months and above. Venous blood samples will be collected from participants aged 5 years and older, and dried blood spot will be collected from children under 5 years. Samples will be shipped to a central laboratory and analysed. Haemoglobin PoC will be administered to all participants. All data will be collected directly on an electronic case report form using tablets, and uploaded to an electronic database. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05389540
Study type	Observational
Source	University of Oxford
Contact
Status	Completed
Phase
Start date	October 3, 2022
Completion date	December 10, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06055777` - Study of the Safety, Tolerability, and PK of SZEY-2108 Administered Intravenously to HVs in SAD and MAD Cohorts	Phase 1
Recruiting	`NCT05793983` - S100A8/A9 and Innate Immunity in Liver Disease
Active, not recruiting	`NCT05963269` - The Effect of the Game on Students' Intramuscular Injection Skills	N/A
Not yet recruiting	`NCT02222779` - Quantification of Transition Metals	N/A
Completed	`NCT01976234` - Stored RBC Transfusion and Immonomodulation	N/A
Completed	`NCT02345135` - Susceptibility to Infections in Ataxia Telangiectasia	N/A
Completed	`NCT01530763` - Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)	Phase 2/Phase 3
Completed	`NCT01158560` - A Trial of Vitamin D and Health Advice for the Prevention of Upper Respiratory Tract Infections	Phase 3
Completed	`NCT01176786` - Reusable Versus Disposable Draping System in Breast Reconstruction Surgery	N/A
Active, not recruiting	`NCT05284097` - Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study	Phase 2
Enrolling by invitation	`NCT06055712` - Antibiotic Prophylaxis in Pediatric Open Fractures	Phase 4
Not yet recruiting	`NCT06338345` - Pharmacokinetics and Modelling of Beta-Lactam in ECMO-VA Patients	N/A
Recruiting	`NCT06002685` - Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention	N/A
Completed	`NCT02802059` - E. Coli Nissle 1917 - Suspension for Infection Prophylaxis	Phase 3
Completed	`NCT05289674` - The Effect of Lactoferrin in High Calorie Formula on IL-6 and IL10 in Children With Failure to Thrive and Infection	N/A
Recruiting	`NCT05770765` - Creation of a Bank of Biological Materials and Associated Data Related to Patients With Infectious and Tropical Diseases
Completed	`NCT05080920` - Rosmalip® for Cancer Infections Prevention	N/A
Recruiting	`NCT05287438` - Next Generation Sequencing Versus Traditional Cultures for Clinically Infected Penile Implants: Impact of Culture Identification on Outcomes	N/A
Recruiting	`NCT05610098` - Gene Expression Profiles in Spinal Tuberculosis.
Recruiting	`NCT06178822` - Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Rural South and Southeast Asia Household Health Survey — SEACTN-HHS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms